precision medicine

The health research platform has already helped enroll 356,000 participants into the nationwide research program.

The roughly three-year-old company says it now has a post-money valuation over $1 billion.

The advantages to health and human service delivery in a bot workforce include speed, reliability, consistency and cost-effectiveness. Sound too far-fetched for your management team? We would disagree.  

Insights into personalized genomics can help prevent diseases in outer space. 

An interview with Hakim Yadi, chief executive and cofounder of Closed Loop Medicine.

The Singapore-MIT Alliance for Research and Technology (SMART), together with A*STAR Institutes and supported by the National Research Foundation (NRF), has launched a new national initiative dubbed Critical Analytics for Manufacturing Personalised-Medicine (CAMP).

Flare Capital Partners offers an overview of sequencing options, opportunities for integration into clinical workflow and the companies making that happen.

The companies' partnership is yet another example of real-world data analysis coming to clinical trials.

According to Moshe Bar Siman-Tov, director general of Israel's Ministry of Health, the country is pushing towards preventative and personalized medicine.

BGN Technologies, the technology transfer company of Ben-Gurion University (BGU), today unveiled an artificial intelligence (AI) platform for monitoring and predicting the progression of neurodegenerative diseases for the purpose of identifying markers for personalised patient care and improved drug development.